Stanford Cancer Institute — Stanford, California

Stanford Cancer Institute is a clinical research site located in Stanford, California, United States 94305.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute has participated in 69 clinical trials with 23 currently active.

Therapeutic areas: Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia.

Sponsors: Blueprint Medicines Corporation, Kite, A Gilead Company, University of Alabama at Birmingham.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stanford

Browse all research sites in California · View every site in Stanford

• Stanford University School of Med /ID# 236922
• Stanford Hospitals and Clinics
• Stanford University School of Med /ID# 242809
• Stanford University School of Medicine; Stanford Hospital Pharmacy
• Stanford hospital & Clinics; Investigational Drug Services
• Stanford University Medical School
• Stanford University Medical Center Stanford Comprehensive Cancer Center
• Stanford Medical Center and Lucile Packard Children's Hospital
• Stanfor University
• Stanford University Department of Pediatric Endocrinology
• Stanford University Medical Center Stanford
• University of Stanford Medical Center

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute?

Stanford Cancer Institute has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute conducted?

Stanford Cancer Institute has 69 clinical trials on record, with 23 currently active. Their work covers Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia.

Is Stanford Cancer Institute accredited by Crixeo Clinical Trials?

Stanford Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.